263 related articles for article (PubMed ID: 22398730)
21. Extracellular Amyloid Deposits in Alzheimer's and Creutzfeldt-Jakob Disease: Similar Behavior of Different Proteins?
Jankovska N; Olejar T; Matej R
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374972
[TBL] [Abstract][Full Text] [Related]
22. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
23. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
24. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease.
Ishii T; Haga S; Yagishita S; Tateishi J
Appl Pathol; 1984; 2(6):370-9. PubMed ID: 6400466
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
26. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
[TBL] [Abstract][Full Text] [Related]
28. Is brain copper deficiency in Alzheimer's, Lewy body, and Creutzfeldt Jakob diseases the common key for a free radical mechanism and oxidative stress-induced damage?
Deloncle R; Guillard O
J Alzheimers Dis; 2015; 43(4):1149-56. PubMed ID: 25125459
[TBL] [Abstract][Full Text] [Related]
29. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
30. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH
J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
[TBL] [Abstract][Full Text] [Related]
31. Tauopathy in human and experimental variant Creutzfeldt-Jakob disease.
Giaccone G; Mangieri M; Capobianco R; Limido L; Hauw JJ; Haïk S; Fociani P; Bugiani O; Tagliavini F
Neurobiol Aging; 2008 Dec; 29(12):1864-73. PubMed ID: 17560687
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
33. Patterns of Tau and α-Synuclein Pathology in the Visual System.
Rahimi J; Milenkovic I; Kovacs GG
J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
[TBL] [Abstract][Full Text] [Related]
34. The involvement of the ubiquitin system in Alzheimer's disease (review).
Pallares-Trujillo J; Lopez-Soriano FJ; Argilés JM
Int J Mol Med; 1998 Jul; 2(1):3-15. PubMed ID: 9854137
[TBL] [Abstract][Full Text] [Related]
35. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
36. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
37. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
38. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
39. The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins.
Rossi M; Kai H; Baiardi S; Bartoletti-Stella A; Carlà B; Zenesini C; Capellari S; Kitamoto T; Parchi P
Acta Neuropathol Commun; 2019 Apr; 7(1):53. PubMed ID: 30961668
[TBL] [Abstract][Full Text] [Related]
40. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]